Literature DB >> 30526007

Association of Genetic Variants of NLRP4 with Exacerbation of Asthma: The Effect of Smoking.

Soo-Taek Uh1, Jong-Sook Park2, So-My Koo1, Yang-Ki Kim1, Ki Up Kim1, Mi-Ae Kim3, Seung-Woo Shin4, Ji-Hye Son5, Heung-Woo Park6, Hyoung Doo Shin7, Choon-Sik Park2,4, Hun Soo Chang5.   

Abstract

Asthma exacerbation is induced by the interaction of genes and environmental factors such as cigarette smoke. NLRP4 counteracts the activity of the inflammasome, which is responsible for asthma exacerbation. In this study, we analyzed the association of single-nucleotide polymorphisms of NLRP4 with the annual rate of exacerbation and evaluated the additive effect of smoking in 1454 asthmatics. Asthmatics possessing the minor allele of rs1696718G > A had more frequent exacerbation episodes than those homozygous for the common allele (0.59 vs. 0.36/year) and the association was present only in current and ex-smokers. There was a significant interaction between the amount smoked and rs16986718 genotypes (p = 0.014) and a positive correlation between the number of annual exacerbation episodes and amount smoked only in rs16986718G > A AA homozygotes. The prevalence of frequent exacerbators (≥2 exacerbation episodes/year) was 2.5 times higher in rs16986718G > A minor allele homozygotes than in common allele homozygotes (12.0% vs. 5.9%). Furthermore, the prevalence was 6 times higher in rs16986718G > A minor allele homozygotes who were current and ex-smokers than in nonsmokers (25.6% vs. 4.1%). The minor allele of rs16986718G > A in NLRP4 may be a genetic marker that predicts asthma exacerbation in adult asthmatics who smoke.

Entities:  

Keywords:  NLRP4; asthma; exacerbation; gene-environment interaction; inflammasome; single nucleotide polymorphism; smoking

Mesh:

Substances:

Year:  2018        PMID: 30526007     DOI: 10.1089/dna.2018.4433

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  6 in total

Review 1.  Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation.

Authors:  Naveen Challagundla; Bhaskar Saha; Reena Agrawal-Rajput
Journal:  Immunol Res       Date:  2022-05-24       Impact factor: 4.505

Review 2.  Innate immunity in allergy.

Authors:  Kazuhiko Maeda; Matias J Caldez; Shizuo Akira
Journal:  Allergy       Date:  2019-04-14       Impact factor: 13.146

3.  Molecular mechanisms of An-Chuan Granule for the treatment of asthma based on a network pharmacology approach and experimental validation.

Authors:  Xiao-Li Chen; Qing-Ling Xiao; Zhong-Hua Pang; Cheng Tang; Qi-Yong Zhu
Journal:  Biosci Rep       Date:  2021-03-26       Impact factor: 3.840

4.  Association of genetic variants of oxidative stress responsive kinase 1 (OXSR1) with asthma exacerbations in non-smoking asthmatics.

Authors:  Min-Hye Kim; Hun Soo Chang; Jong-Uk Lee; Ji-Su Shim; Jong-Sook Park; Young-Joo Cho; Choon-Sik Park
Journal:  BMC Pulm Med       Date:  2022-01-04       Impact factor: 3.317

5.  The protective effects of the methylenetetrahydrofolate reductase rs1801131 variant among Saudi smokers.

Authors:  Mikhlid H Almutairi; Nouf S Al-Numair; Narasimha Reddy Parine; Bader O Almutairi; Abdulwahed F Alrefaei; Mahmoud Rouabhia; Abdelhabib Semlali
Journal:  Saudi J Biol Sci       Date:  2021-04-13       Impact factor: 4.219

6.  A twelve-gene signature for survival prediction in malignant melanoma patients.

Authors:  Le-Bin Song; Qi-Jie Zhang; Xiao-Yuan Hou; Yan-Yan Xiu; Lin Chen; Ning-Hong Song; Yan Lu
Journal:  Ann Transl Med       Date:  2020-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.